Profil
Dr. Hella Kohlhof is a Chief Scientific Officer at Immunic, Inc. Dr. Kohlhof was previously employed as a Chief Science Officer by Vital Therapies, Inc., a Director-Projects Development by 4SC AG, and a Managing Director by Immunic Research GmbH.
She received her doctorate degree from Ludwig-Maximilians-Universität München.
Aktiva positioner av Hella Kohlhof
| Företag | Position | Start |
|---|---|---|
| IMMUNIC, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2017-01-01 |
Tidigare kända positioner av Hella Kohlhof
| Företag | Position | Slut |
|---|---|---|
Immunic Research GmbH | Verkställande Direktör | - |
| 4SC AG | Företagsledare/Principal | - |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Teknisk/Vetenskaplig/F&U Direktör | - |
Hella Kohlhofs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
4SC AG
4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Immunic Research GmbH |
















